 |
上海源葉生物科技有限公司
主營(yíng)產(chǎn)品： S30260異硫氰酸胍,30259鹽酸胍,嗜熱菌蛋白酶 |
會(huì)員.png)
14
聯(lián)系電話
15921386130
公司信息
- 聯(lián)系人：
- 何小姐
- 電話：
- 86-021-61559134
- 手機(jī)：
- 15921386130
- 傳真：
- 86-021-55068248
- 地址：
- 上海市松江區(qū)長(zhǎng)塔路465號(hào)6幢
- 郵編：
- 200433
- 網(wǎng)址：
- www.shyuanye.com
S80128
| 參考價(jià) | 面議 |
具體成交價(jià)以合同協(xié)議為準(zhǔn)
- 型號(hào)
- 品牌
- 廠商性質(zhì) 生產(chǎn)商
- 所在地
更新時(shí)間：2024-07-04 07:24:27瀏覽次數(shù)：107
聯(lián)系我們時(shí)請(qǐng)說(shuō)明是化工儀器網(wǎng)上看到的信息，謝謝!
- 提示：詳情請(qǐng)下載說(shuō)明書。
- 產(chǎn)品描述： Dofetilide is a sulfonamide class III antiarrhythmic agent and potassium channel blocker. Dofetilide selectively blocks cardiac ion channels of the rapid component of the delayed rectifier potassium current Ikr. This antiarrhythmic agent prolongs cardiac action potential duration and effective refractory period due to delayed repolarization without affecting conduction velocity. This results in a normal sinus rhythm. Dofetilide is used in the treatment of atrial fibrillation and flutter.
- 靶點(diǎn)： Potassium Channel
- 體內(nèi)研究： Dofetilide (100 mg/kg, i.v.) does not suppress automaticity arrhythmias induced by two-stage coronary ligation and epinephrine or the coronary ligation and reperfusion arrhythmias, but suppresses the reentry arrhythmia induced by PES in dogs with old myocardial infarction (MI). Dofetilide also shows antiarrhythmic effect in some dogs with digitalis arrhythmia. Dofetilide increases QT interval and shows negative chronotropic effect like that of other class III drugs, but is different in antiarrhythmic profiles from those of other class III agents such as D-sotalol, E-4031, and MS-551 in that it does not prevent the occurrence of ventricular fibrillation (VF) immediately after coronary reperfusion and has some antiarrhythmic effects on digitalis arrhythmia. Dofetilide causes increased resorptions and the same stage-dependent malformations in Sprague-Dawley rats.
- 參考文獻(xiàn)：
1. Webster WS, et al. Teratology, 1996, 53(3), 168-175. 2. Bauer A, et al. J Cardiovasc Pharmacol, 2002, 39(3), 460-467. 3. Kiehn J, et al. Circulation, 1996, 94(10), 2572-2579. 4. Kiehn J, et al. J Cardiovasc Pharmacol, 1994, 24(4), 566-572. 5. Chen J, et al. J Cardiovasc Pharmacol, 1996, 28(4), 576-584.
- 溶解度： Soluble in DMSO
- 保存條件： Store in original container in a cool dark place.
- 配置溶液濃度參考：
1mg 5mg 10mg 1 mM 2.265 ml 11.323 ml 22.647 ml 5 mM 0.453 ml 2.265 ml 4.529 ml 10 mM 0.226 ml 1.132 ml 2.265 ml 50 mM 0.045 ml 0.226 ml 0.453 ml
- 注意：部分產(chǎn)品我司僅能提供部分信息，我司不保證所提供信息的性，僅供客戶參考交流研究之用。
